DrugsControl Media Services
DrugsControl.org

News Detail

Clinical trials: US FDA proposes new standards for collecting race, ethnicity data (31-01-2024)

Maryland, 31 Jan 2024: The US Food and Drug Administration (FDA) is outlining a standardized approach for collecting and reporting on race and ethnicity data in clinical trials and studies in a new draft guidance document.
 
“Using standardized terminology fo......
View Details

Source : Regulatory Focus
US Food and Drug Administration (FDA) race and ethnicity data clinical trials new draft guidance document

Related News